Basket cover image
15 handpicked stocks

Rest & Recharge

Tap into the booming wellness economy with companies revolutionizing how we sleep and relax. These carefully selected stocks represent innovative leaders in sleep technology, relaxation services, and wellness solutions that are responding to our growing desire for better rest and recovery.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at जून 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

SNBR

Sleep Number Corporation

SNBR

Current price

$7.62

The company provides smart beds and wellness technology specifically engineered to improve sleep quality.

PRPL

Purple Innovation Inc

PRPL

Current price

$1.09

This comfort technology company designs and sells mattresses, pillows, and other products central to restful sleep.

INSP

Inspire Medical Systems, Inc.

INSP

Current price

$90.08

It develops and commercializes implantable neurostimulation technology for treating obstructive sleep apnea.

About This Group of Stocks

1

Our Expert Thinking

The world is increasingly prioritizing wellness, with quality sleep and relaxation becoming essential purchases rather than luxuries. These companies are at the forefront of this shift, offering everything from smart mattresses and sleep tracking technology to medical devices and relaxation services.

2

What You Need to Know

This collection blends established consumer brands with innovative healthcare and technology companies. You'll find a mix of stable bedding manufacturers alongside cutting-edge medical device makers targeting sleep disorders and mental wellness—providing both defensive consumer stability and healthcare growth potential.

3

Why These Stocks

These companies were strategically selected to capture the full spectrum of the "Rest & Recharge" economy. From sleep diagnostics and therapeutics to comfort products and relaxation services, each company addresses a specific aspect of our growing need for better rest in an increasingly busy world.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+70.02%

Group Performance Snapshot

70.02%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 70.02% over the next year.

11 of 14

Stocks Rated Buy by Analysts

11 of 14 assets in this group are rated Buy by professional analysts.

17.6% vs 4%

Group Growth vs Bank interest

This group averaged a 17.6% return last month, beating the typical 4% bank rate.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

😴

Sleep is the New Luxury

As burnout reaches epidemic levels, people are spending more on quality sleep products and services than ever before. These companies are positioned to benefit from this powerful shift in consumer priorities.

📱

Tech Meets Wellness

The intersection of technology and wellness is creating entirely new product categories. From sleep tracking wearables to smart beds, these innovations are transforming how we understand and improve our rest.

💊

The Medical Sleep Revolution

Sleep disorders affect millions globally, but breakthrough treatments are emerging. Companies developing solutions for conditions like sleep apnea and insomnia are tapping into a massive, underserved market.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.